SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001193125-24-237753
Filing Date
2024-10-16
Accepted
2024-10-15 21:39:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC14D9C d891574dsc14d9c.htm SC14D9C 18416
  Complete submission text file 0001193125-24-237753.txt   20065
Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775
Longboard Pharmaceuticals, Inc. (Filed by) CIK: 0001832168 (see all company filings)

IRS No.: 845009619 | Fiscal Year End: 1231
Type: SC14D9C
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775
Longboard Pharmaceuticals, Inc. (Subject) CIK: 0001832168 (see all company filings)

IRS No.: 845009619 | Fiscal Year End: 1231
Type: SC14D9C | Act: 34 | File No.: 005-92379 | Film No.: 241373118
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)